PolarSeal®, a pioneering force in advanced manufacturing, proudly announces its participation in the highly anticipated MD&M West 2024, a premier event for medical design and manufacturing. This timely move follows the recent declaration of PolarSeal®'s ambitions to establish a manufacturing arm in the USA.
Read MorePolarSeal®, a prominent provider of medical device contract manufacturing and adaptable material conversion, is excited to announce its strategic manufacturing expansion plans into the United States, targeting the dynamic Med-Tech market and the burgeoning Medical Manufacturing sectors.
Read MorePolarSeal®, a leading medical device contract manufacturer and flexible material converter, is pleased to announce the launch of its new Training Academy - "Operational Excellence" - a training program designed to enhance the skills and knowledge of its workforce and ensure that they are equipped with the necessary skills.
Read MoreThe verification and validation of medical software is coming under increased scrutiny by the U.S. FDA. This webinar will address the use of the FDA, GAMP, 21 CFR Part 11, Electronic Records coupled with the ISO 14971 / ICH Q9 Product Risk Management models.
Read MoreacroMIS, an International Medical Consulting firm in California, published a series of three articles describing the process for off-shoring and implementation of U.S. medical device innovation in Europe. Free @ http://www.implementation.acromis.com/
Read More